Вы находитесь на странице: 1из 29

: , 558.

, -
, 417, -
: , ...

1. -
.
, ..
,
.

18-20 . ;
4-6
.

100 .
140 2000. 343
2007.
:
2000. 400
., 2003. - 700 . ( 71%)

.1:

..

2. -


.


79,9%.
6 . 7,6%.
6 .

2.1. : ,
, ,

- ;
- ;
-
.

- ;
- .

- : -,
-10, -6;
- ;
- - .

2.2.
- ?
:
;
- ;
;
;
;
( 2- )
;
;
;
;
, .

2.3.
.
:
1) ;
2)
24-48 . ,
: , , ;
3) 48 . ;
4) - 25-30 .;
5) - 25%.

.2:

3.
2005 .


,
,
, ,


,

,

.3:

4.1. :
, , .
: ?

.4: ;
Fukui Y, Okamura Y. Clinical performance of a point-of-care assay for
measurement of presepsin in patients with bacteremia. Critical Care 2013

4.1. :
, , .
=
;
=
.

=
;
=
.

.5:

Noto A et al. Soluble CD14-Subtype (sCD14-ST) Presepsin In Critically Ill Preterm And Term
Newborns For The Early
Assessment Of Neonatal Sepsis: Preliminary Results

4.1. :
, , .
:
+,
- .
,
?

4.2.
:
?

.6:
Shozushima T, Takahashi G, Matsumoto N et al. Usefulness of presepsin (sCD14-ST)
measurements as a marker for the diagnosis and severity of sepsis that satisfied
diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother.

4.2.

.6: ,
Liu B, Chen YX, Yin Q et al, Diagnostic value and prognostic evaluation of
Presepsin for sepsis in an emergency department.Crit Care. 2013

4.2.
:
?

.6: , -, -10, -6,


.
Shirakawa K, Naitou K, Hirose J et al. The new sepsis marker, sCD14-ST, induction
mechanism in the rabbit sepsis models. Critical Care 2010

4.2.
:

,
,
.
?
, ;

4.3.

APACHE II, SOFA

.7: SOFA APACHE II


Kojika M, Takahashi G, Matsumoto N, et al: Serum levels of soluble CD14 subtype
reflect the APACHE II and SOFA scores.

4.3.

APACHE II, SOFA

-6

.7: , , -6
, SOFA

Endo S, Suzuki Y, Takahashi G et al Presepsin as a powerful monitoring tool for the


prognosis and treatment of sepsis:A multicenter prospective study. J Infect Chemother

4.3.
T 1\2() =
30. -1.
T 1\2() =
25-30 .

.7:
Shirakawa K. Diagnosis of Respiratory Tract Infectious Disease using
urine specimens. European Patent Application

4.3.

APACHE II, SOFA
:
SOFA
APACHE II.
(30 . 1.),
, ,-6 ,

SOFA \ APACHE II/

SOFA \ APACHE II

,
.

4.7. .
:

?

.8: .
Sargentini V, Ceccarelli G, D'Alessandro M et al. Presepsin as a potential
marker for bacterial infection relapse in critical care patients.

4.7. .
:



4.8.
,

. 9: .
Spanuth E, Giannitsis E. Diagnosis of sespis and monitoring of weaning from
mechanical ventilation in critical ill patients by PATHFAST Presepsin. 20th IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine 19-23
May 2013

4.9.
.


?
.
.

5. :

6.1.:
1.
.
2.

(-, -6, -10, )
3.
, .
4. (!)
,

6.2.()
5. 100% ,
:
)
,
) .
6. , :
) ;
)
;
) ,

.
7. ,
, ,
, .